Common to all the treated tumors was the upregulation of CD49a expression on intratumoral NK cells, enhanced CCL5 production, and increased granzyme and perforin expression consistent with heightened cytotoxicity and their contribution to the enhanced anti-tumor response. The gene discussed is ITGA1; the disease is neoplasm.